Submit Press Release GroupWeb News Network Africa Alabama Alaska Arizona Arkansas Asia California China Colorada Connecticut Washington DC Delaware Florida France Georgia Germany Ghana Hawaii Idaho Illinois India Indiana Iowa Italy Japan Kansas Kentucky Korea Lousiana Main MaryLand Massachusetts Michigan Minnesota Mississippi Misouri Motana Nebraska Nevad New Hampshire New Jersey New Mexico New York Nigeria North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island Rhode Island Russia South Africa South Carolina South Dakota Spain Tennessee Texas UK Utah Vermont Virginia Washington Weather West Virginia Wisconsin

Home | Search Global IT News: IT News & Press Release Distribution: Artificial Stem Cells Market worth $37 million by 2028, at a CAGR of 22.5%   Artificial Stem Cells Market (IT-NEWSWIRE.COM, August 20, 2019 ) According to the new market research report "Artificial Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada}, Europe, APAC, RoW) - Global Forecast to 2028", published by MarketsandMarkets™ The major factors driving the Artificial Stem Cells Market include ethical concerns regarding embryonic stem cells and the risk of tumor formation and immune rejection of natural stem cells. The cardiovascular diseases segment is expected to command the largest share of the overall Artificial Stem Cells Market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435 The Artificial Stem Cells Market, by application, is estimated to be dominated by the cardiovascular diseases segment in 2023. This is attributed to the fact that the Artificial Stem Cellss have been firstly developed for cardiac tissue and are tested in mice models. After the successful pre-clinical testing of cardiac Artificial Stem Cellss, these cells will enter the clinical phase of development and are expected to hit the market by 2023. Browse and in-depth TOC on "Artificial Stem Cells Market" 4 - Tables 17 - Figures 55 - Pages North America to lead the Artificial Stem Cells Market with accelerated R&D activities in stem cell therapy research. North America is estimated to account for the largest share of the market in 2023. North America is the pioneer of Artificial Stem Cells technology. Also, North America leads in the R&D of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018. This is further backed by the high rate of adoption of advanced therapies in the US (more than 600 stem cell therapy clinics in the US in 2016). Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435 The key developers of Artificial Stem Cells technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China). MarketsandMarkets™ Mr. Shelly Singh 1-888-600-6441 raviraj.tak@marketsandmarkets.com Source: EmailWire.Com Source: EmailWire.com

Information Technology Resources Application Software Bioinformatics Computers Computer Games Enterprise Software Graphics/Printing/CAD Hardware/Peripheral industrial Computers Information Internet Multimedia Networking Public Sector Robotics Semiconductor Software Telecommunications Webmaster Information Technology (IT) Advertisement Information Technology Sponsors Information Technology Publications We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Information Technology resource center today to browse our selection of 600+ complimentary Information Technology magazines, white papers, webinars, podcasts, and more. Get popular titles including: The Integration Journey—a Field Guide to Enterprise Integration for SOA Government Technology\'s Public CIO Protecting Content During Business Disruption: Are You Covered? No credit cards, coupons, or promo codes required. Try it today!